lundi 27 mars 2017

Onco Actu du 27 mars 2017

1. Biologie

Rethinking a Cancer Drug Target [The Scientist]

2.5 Etiologie - Gènes

Reports that cancer is ‘mainly bad luck’ make a complicated story a bit too simple [Cancer Research UK]

The ‘Bad Luck’ Cancer Analysis, Part II [ACS]

4.12 Biopsies liquides

Software detects early-stage cancer DNA using epigenetic markers [FierceBiotech]

4.2 Dép., diag. & prono. - Génome

Every child with cancer to have tumour DNA sequenced to find best treatment [The Telegraph]

4.5 Dép., diag. & prono. - Colorectal

Reaching Beyond Delivery System Walls To Improve Colorectal Cancer Screening [Health Affairs Blog]

4.9 Dép., diag. & prono. - Sein

Breast Cancer Detection Using Ultrasound: Interview with Dr. Georgia Giakoumis Spear, NorthShore University Health System [medGadget]

5.2.1 Pharma - Partenariats

Ignyta agrees new terms with Lilly for troubled cancer alliance [FierceBiotech]

5.2.2 Pharma - Fusions & Acquisitions

That $95M Merck gamble to acquire cCAM? It didn’t pay off. [EndPoints]

5.3.4 Traitements - AMM (FDA, EMA)

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) for the Treatment of Squamous Cell Cancer of the Head and Neck in Adults Progressing on or After Platinum-based Therapy [BMS]

European Medicines Agency’s CHMP Recommends Approval of Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma [Merck]

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 March 2017 [EMA]

Chinese drug approval boosts AstraZeneca's lung cancer hopes [Reuters]

5.4 Traitements - Economie

NICE asks BMS for more data before approving cancer drug [European Pharmaceutical Review]

6.1 Observation

Can the contraceptive pill protect women from cancer? [The Guardian]

6.10.1 Politiques (USA)

New coalition formed to fight back against Trump’s desired NIH cuts [FierceBiotech]

Drug Companies Are Buying Ads on Shows They Know Donald Trump Watches [Bloomberg]

6.6 Publications

Researching the researchers: meet Stanford school's 'Cassandra' of fake news [Wired]

The Readability Of Scientific Texts Is Decreasing Over Time [bioRxiv]

6.7 DMP, Big Data & applis

A.I. versus M.D. [The New Yorker]

6.8 Communication

‘Not statistically significant but clinically meaningful’: A researcher calls ‘BS’ on cancer drug spin [HealthNewsReview]